CN1362084A - Nano coronary heart disease treating red sage medicine and its preparation - Google Patents
Nano coronary heart disease treating red sage medicine and its preparation Download PDFInfo
- Publication number
- CN1362084A CN1362084A CN 01100067 CN01100067A CN1362084A CN 1362084 A CN1362084 A CN 1362084A CN 01100067 CN01100067 CN 01100067 CN 01100067 A CN01100067 A CN 01100067A CN 1362084 A CN1362084 A CN 1362084A
- Authority
- CN
- China
- Prior art keywords
- nano
- red sage
- chinese
- heart disease
- coronary heart
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a nano Zuogui preparation. It comprises materials such as nano prepared rehmannia root, nano fruit of Chinese wolfberry, anno Chinese yam, nano cornel, nano seed of Chinese dodder, nano antler glue, nano tortoise-plastron glue, nanoRadix cyathulae, making up in proportion and to be fabricated into new medicine drug. Its particle fineness is 1200-1500 mesh and particle size 0.1-200nm and most of the particle size is shorter than 100nm and has new material properties. It is fabricated through steps such as microwave extraction, decompression and concentration, supersonic jet and spray drying.
Description
The present invention relates to a kind of blood circulation promoting and blood stasis dispelling, regulating QI to relieve pain, cure mainly the nano coronary heart disease treating red sage preparation medicine of coronary heart disease, the invention still further relates to the method for this medication preparation.
GUANXIN DANSHEN PIAN is a kind of classical Chinese patent medicine, mainly contains effects such as increasing coronary flow, blood pressure lowering, decreasing heart rate, is used for uncomfortable in chest, the thoracic obstruction, shortness of breath and palpitation due to the coronary heart disease.But traditional GUANXIN DANSHEN PIAN disintegrate is slower, absorbs not exclusively, and bioavailability is not high, slow curative effect.
The object of the present invention is to provide a kind of bioavailability height, solid dispersion is good, absorbs fully the nano coronary heart disease treating red sage preparation medicine of increase evident in efficacy.
Another object of the present invention provides the preparation method of this nano coronary heart disease treating red sage preparation medicine.
To achieve these goals, the present invention takes following technical scheme:
Medicine of the present invention is to make (consumption is a weight portion) by following component:
Nano red sage 120-280 part nanometer Radix Notoginseng 120-280 part nanometer Lignum Dalbergiae Odoriferae oil 1.0-2.5 part
The formula optimization weight proportion scope of medicine of the present invention is:
Nano red sage 160-240 part nanometer Radix Notoginseng 160-240 part nanometer Lignum Dalbergiae Odoriferae oil 1.2-2.3 part
The optimum weight proportioning of medicine of the present invention is:
1.75 parts of 200 parts of nanometer Lignum Dalbergiae Odoriferae oils of 200 parts of nanometer Radix Notoginseng of nano red sage
Technical scheme of the present invention is based on the modern material technology.One of modern material Developing Trend in Technology is to develop to the more and more littler direction of yardstick.The granule of the past composition material, its size all are at micron or more than the millimeter magnitude, and have occurred the material to the nanoscale development now.Because extremely refinement of granule, the shared percentage by volume of crystal boundary increases, and makes some performance of material that outstanding variation take place.
The property of nano material is because the special construction of nano material---the particle size of material is less than the ultra-micro powder of 100nm, its body surface area is very big, the atom number ratio at crystal boundary place makes it to produce four big effects up to 15%-50%: i.e. small-size effect, quantum effect (containing macro quanta tunnel effect), skin effect and interfacial effect.Thereby has the not available physical and chemical performance of traditional material.Nanotechnology will bring a technological revolution of the field of Chinese medicines.
One of method of above-mentioned each component being made medicine of the present invention is:
1. divide and get the Chinese crude drug of respectively distinguishing the flavor of, add to concoct according to Chinese Pharmacopoeia one one of version in 2000 and be processed into the common Chinese decoction pieces
2. divide and get the common Chinese decoction pieces of respectively distinguishing the flavor of, be processed into the nanometer prepared slices of Chinese crude drugs, its method comprises the following steps:
1. the common Chinese decoction pieces is placed extraction pot, solubilizer also imports microwave extracting, makes its speed with 20-30 hundred million times/second do the change in polarity motion, and the temperature of its microwave extracting is 30 ℃-60 ℃, time 1-10 hour;
2. above-mentioned extract is carried out concentrating under reduced pressure, temperature is 30 ℃-60 ℃, and the time is 3-72 hour, collects volatile material in the Chinese medicine simultaneously in addition;
3. decompressed concentrate and volatile material merging are placed spray drying tower, use the supersonic jet technology, 330 meters-990 meter per seconds of effluxvelocity, 30 ℃ of-60 ℃ of temperature, under 0 to the 0.05MPa pressure,, promptly make the nanometer prepared slices of Chinese crude drugs with the instantaneous drying of hypersonic velocity.
3. the nanometer prepared slices of Chinese crude drugs (powder) are prepared mixing in described ratio, according to Chinese Pharmacopoeia version two-shift system in 2000 agent standard, make pill, powder, tablet, suppository, granule, membrane, capsule, microcapsule, drop pill, aerosol, injection, unguentum, medicated wine, syrup, oral solution.
Two of medicine method for making of the present invention is:
1. be equipped with whole common Chinese decoction pieces in the proportioning ratio, place extraction pot, solubilizer also imports microwave extracting, makes its speed with 20-30 hundred million times/second do the change in polarity motion, and the temperature of its microwave extracting is 30 ℃-60 ℃, time 1-10 hour;
2. above-mentioned extract is carried out concentrating under reduced pressure, temperature is 30 ℃-60 ℃, and the time is 3-72 hour, collects volatile material in the Chinese medicine simultaneously in addition;
3. decompressed concentrate and volatile material merging are placed spray drying tower, use the supersonic jet technology, 330 meters-990 meter per seconds of effluxvelocity, 30 ℃ of-60 ℃ of temperature, under 0 to the 0.05MPa pressure,, get coronary heart disease preparation nano powder with the instantaneous drying of hypersonic velocity jet;
4. its nano powder is made aforementioned various preparation according to Chinese Pharmacopoeia version standard preparation in 2000.
The pharmacological effect that above-mentioned two kinds of methods are made the nano coronary heart disease treating red sage preparation medicine is identical.
A kind of important feature of the present invention is: the made drug material of the present invention has reached nanoscale, common GUANXIN DANSHEN PIAN preparation material is micron or the above particle diameter of millimeter, can only cross the 80-120 mesh sieve, the drug material that the present invention is made, particle diameter is at 0.1-200nm, the overwhelming majority can be crossed the 1200-1500 mesh sieve less than 100nm.
Another important feature of the present invention is: solid preparation of the present invention disintegrate rapidly, and solid dispersion is good in water, absorb fully, the bioavailability height, the pharmacological action effect that mainly contains effective constituent is significantly higher than conventional formulation.
The pharmaceutical preparation that the present invention is made does not need to add any adjuvant, and is more favourable to human body.
The present invention has also created the new drug formulation that pill, powder, suppository, granule, membrane, capsule, microcapsule, drop pill, aerosol, injection, medicated wine, syrup, oral solution of nano coronary heart disease treating red sage preparation medicine etc. had no precedent in the past.
Pharmaceutical preparation of the present invention can be used for treatment of conditions such as coronary heart disease, and clinical efficacy significantly is better than traditional GUANXIN DANSHEN PIAN.
The present invention's added solvent in microwave extracting is water or ethanol.
The present invention carries out in the concentrating under reduced pressure step at extract, and its concentrating under reduced pressure is conventional scheme.
Embodiment 1:
Prepare nano raw material by preceding method:
1.75 parts of 200 parts of nanometer Lignum Dalbergiae Odoriferae oils of 200 parts of nanometer Radix Notoginseng of nano red sage
Production method is as follows:
In the GMP cleaning shop, after the above-mentioned nanometer prepared slices of Chinese crude drugs or powder prepared mixing in described ratio, according to Chinese Pharmacopoeia version two-shift system in 2000 agent capsules agent standard, do not add adjuvant, do not granulate, directly divide encapsulated with the fully-automatic capsule racking machine, make capsule, every capsules content of dispersion is the 0.1-0.6 gram, and the patient takes 1-4 time every day, each 1-5 grain.
Embodiment 2:
Prepare nano raw material by preceding method:
1.75 parts of 200 parts of nanometer Lignum Dalbergiae Odoriferae oils of 200 parts of nanometer Radix Notoginseng of nano red sage
Production method is as follows:
In the GMP cleaning shop, after the above-mentioned nanometer prepared slices of Chinese crude drugs or powder prepared mixing in described ratio, according to Chinese Pharmacopoeia version two-shift system in 2000 agent powder needle injection standard, do not add any adjuvant, make the nano coronary heart disease treating red sage powder needle injection, every injection content is the 5-20 milligram, and each consumption is that 1-2 props up, and use 1-3 every day.
Embodiment 3:
Prepare nano raw material by preceding method:
1.75 parts of 200 parts of nanometer Lignum Dalbergiae Odoriferae oils of 200 parts of nanometer Radix Notoginseng of nano red sage
Production method is as follows:
In the GMP cleaning shop, after the above-mentioned nanometer prepared slices of Chinese crude drugs or powder prepared mixing in described ratio, according to Chinese Pharmacopoeia version two-shift system in 2000 agent membrane standard, filmogen adopts polyvinyl alcohol, make the nano coronary heart disease treating red sage membrane, every membrane area size is the 2-100 square centimeter, and content of dispersion is the 1-50 gram, every medicine film pasted 1-7 days, pasted the medicine position: chest.
Claims (6)
1, a kind of nano coronary heart disease treating red sage preparation medicine is characterized in that it is the medicament that the nano raw material of following weight proportioning is made:
Nano red sage 120-280 part nanometer Radix Notoginseng 120-280 part nanometer Lignum Dalbergiae Odoriferae oil 1.0-2.5 part
And adopt following method to make: to select the formula Chinese drug material to concoct and be processed into the prepared slices of Chinese crude drugs; Place extraction pot, solubilizer also imports microwave extracting, makes it do the change in polarity motion with hundred million times/second speed of 20--30, and the temperature of its microwave extracting is 30--60 ℃, time 1--10 hour; Above-mentioned extract is carried out concentrating under reduced pressure, and temperature is 30--60 ℃, and the time is 3--72 hour, collects volatile material in the Chinese medicine simultaneously in addition; Decompressed concentrate and volatile material merging are placed spray drying tower, use the Supersonic fluidics, 30--60 ℃ of temperature, under 0 to the 0.05MPa pressure, with hypersonic velocity instantaneous jet drying, wherein supersonic jet speed is 330 meters--990 meter per seconds, promptly make the nanometer prepared slices of Chinese crude drugs.
2, nano coronary heart disease treating red sage preparation medicine according to claim 1, wherein the weight proportion of each nano raw material is:
Nano red sage 160-240 part nanometer Radix Notoginseng 160-240 part nanometer Lignum Dalbergiae Odoriferae oil 1.2-2.3 part
3, nano coronary heart disease treating red sage preparation medicine according to claim 1, wherein the weight proportion of each nano raw material is:
1.75 parts of 200 parts of nanometer Lignum Dalbergiae Odoriferae oils of 200 parts of nanometer Radix Notoginseng of nano red sage
4,, it is characterized in that said medicine is pill, powder, tablet, suppository, granule, membrane, capsule, microcapsule, drop pill, aerosol, injection, unguentum, medicated wine, syrup, oral solution according to claim 1 or 2 or 3 described nano coronary heart disease treating red sage preparation medicines.
5,, it is characterized in that this method comprises the steps: to select the formula Chinese drug material to concoct and is processed into the prepared slices of Chinese crude drugs according to the pharmaceutical methods of claim 1 or 2 or 3 described nano coronary heart disease treating red sage preparation medicines; Place extraction pot, solubilizer also imports microwave extracting, makes it do the change in polarity motion with hundred million times/second speed of 20--30, and the temperature of its microwave extracting is 30--60 ℃, time 1--10 hour; Above-mentioned extract is carried out concentrating under reduced pressure, and temperature is 30--60 ℃, and the time is 3--72 hour, collects volatile material in the Chinese medicine simultaneously in addition; Decompressed concentrate and volatile material merging are placed spray drying tower, use the Supersonic fluidics, 30--60 ℃ of temperature, under 0 to the 0.05MPa pressure, with hypersonic velocity instantaneous jet drying, wherein supersonic jet speed is 330 meters--990 meter per seconds, promptly make the nanometer prepared slices of Chinese crude drugs.
6, wherein respectively distinguish the flavor of Chinese medicine in the ratio of prescription or Chinese crude drug concoct be processed into the prepared slices of Chinese crude drugs after mixing, or after making the nanometer prepared slices of Chinese crude drugs mixing.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 01100067 CN1362084A (en) | 2001-01-08 | 2001-01-08 | Nano coronary heart disease treating red sage medicine and its preparation |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 01100067 CN1362084A (en) | 2001-01-08 | 2001-01-08 | Nano coronary heart disease treating red sage medicine and its preparation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN1362084A true CN1362084A (en) | 2002-08-07 |
Family
ID=4651270
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 01100067 Pending CN1362084A (en) | 2001-01-08 | 2001-01-08 | Nano coronary heart disease treating red sage medicine and its preparation |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1362084A (en) |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1778327B (en) * | 2004-11-26 | 2010-05-12 | 天津天士力制药股份有限公司 | Medicine dropping pill for treating cardiovascular disease |
| CN1778326B (en) * | 2004-11-26 | 2010-08-25 | 天津天士力制药股份有限公司 | Medicine for treating cardiovascular disease |
| CN1853670B (en) * | 2005-03-29 | 2010-12-15 | 贵阳云岩西创药物科技开发有限公司 | Coronary heart Danshen root micropellets and preparation thereof |
| CN106511462A (en) * | 2016-07-15 | 2017-03-22 | 中国医学科学院药用植物研究所 | Application of Guanxin salvia miltiorrhiza compound preparation in preparing medicine for improving ventricular remodeling |
| CN108339004A (en) * | 2017-01-21 | 2018-07-31 | 上海市普陀区中心医院 | Effective active position of Chinese medicine Lignum Dalbergiae Odoriferae extract and preparation method thereof |
-
2001
- 2001-01-08 CN CN 01100067 patent/CN1362084A/en active Pending
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1778327B (en) * | 2004-11-26 | 2010-05-12 | 天津天士力制药股份有限公司 | Medicine dropping pill for treating cardiovascular disease |
| CN1778326B (en) * | 2004-11-26 | 2010-08-25 | 天津天士力制药股份有限公司 | Medicine for treating cardiovascular disease |
| CN1853670B (en) * | 2005-03-29 | 2010-12-15 | 贵阳云岩西创药物科技开发有限公司 | Coronary heart Danshen root micropellets and preparation thereof |
| CN106511462A (en) * | 2016-07-15 | 2017-03-22 | 中国医学科学院药用植物研究所 | Application of Guanxin salvia miltiorrhiza compound preparation in preparing medicine for improving ventricular remodeling |
| CN106511462B (en) * | 2016-07-15 | 2019-10-22 | 中国医学科学院药用植物研究所 | Application of the coronary heart disease compound preparation in the drug that preparation improves remodeling ventricle |
| CN108339004A (en) * | 2017-01-21 | 2018-07-31 | 上海市普陀区中心医院 | Effective active position of Chinese medicine Lignum Dalbergiae Odoriferae extract and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1362084A (en) | Nano coronary heart disease treating red sage medicine and its preparation | |
| CN1362199A (en) | Nano girald daphne medicine and its preparation | |
| CN1362196A (en) | Nano Guanxinsuhe medicine and its preparation | |
| CN1365676A (en) | Nano medicine 'Compound berberine' and its preparing process | |
| CN1362141A (en) | Nano Xingxiao bezoar medicine and its preparation | |
| CN1364500A (en) | Nano sanliangban medicine and its preparing method | |
| CN1363297A (en) | Nano medicine 'Anluotong' and its preparing process | |
| CN1368179A (en) | Nano medicine 'Shexiangqutong' and its preparing process | |
| CN1362165A (en) | Nano spirulina medicine and its preparation | |
| CN1362238A (en) | Nano analgesic Rhizome corydalis medicine and its preparation | |
| CN1365713A (en) | Nano medicine for treating ulcer and its preparing process | |
| CN1362147A (en) | Nano mixed red sage medicine and its preparation | |
| CN1362240A (en) | Nano medicine powder for treating cold limbs caused by Yang exhaustion and its preparation | |
| CN1366888A (en) | Nano quicken the blood and disperse welling abscess preparation medicine and preparation method thereof | |
| CN1365768A (en) | Nano 6-component Anxiao medicine and its preparing process | |
| CN1363339A (en) | Nano medicine 'Compound Kendir' and its preparing process | |
| CN1362197A (en) | Nano Diaoxinxuekang medicine and its preparation | |
| CN1363329A (en) | Nano sophora fruit medicine and its preparing process | |
| CN1366899A (en) | Nano dizziness-clearing preparation medicine and preparation method thereof | |
| CN1368121A (en) | Nano medicine 'Jinzeguanxin' and its preparing process | |
| CN1362219A (en) | Nano Zhichuanling medicine for treating asthma and its preparation | |
| CN1368352A (en) | Nano medicine 'Guanxinning' and its preparing process | |
| CN1364560A (en) | Nano astragalus root-acanthopanax medicine and its preparing method | |
| CN1365736A (en) | Nano medicine for treating coronary heart disease and its preparing process | |
| CN1363286A (en) | Nano musk medicine for protecting heart and its preparing process |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C57 | Notification of unclear or unknown address | ||
| DD01 | Delivery of document by public notice |
Addressee: Yang Mengjun Document name: Notification before expiration of term |
|
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |